Operating Lease, Right-of-Use Asset of PUMA BIOTECHNOLOGY, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
PUMA BIOTECHNOLOGY, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • PUMA BIOTECHNOLOGY, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $6,147,000, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

PUMA BIOTECHNOLOGY, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,147,000 +$730,000 +13% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $2,828,000 -$3,403,000 -55% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $3,716,000 -$3,307,000 -47% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $4,579,000 -$3,213,000 -41% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $5,417,000 -$3,123,000 -37% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $6,231,000 -$3,683,000 -37% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $7,023,000 -$3,627,000 -34% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $7,792,000 -$3,570,000 -31% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $8,540,000 -$3,513,000 -29% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $9,914,000 -$2,809,000 -22% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $10,650,000 -$2,723,000 -20% 31 Mar 2023 10-Q 04 May 2023 2022 Q1
Q4 2022 $11,362,000 -$2,655,000 -19% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $12,053,000 -$2,588,000 -18% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $12,723,000 -$2,524,000 -17% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $13,373,000 -$2,461,000 -16% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $14,017,000 -$2,387,000 -15% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $14,641,000 -$2,316,000 -14% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $15,247,000 -$2,247,000 -13% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $15,834,000 -$2,182,000 -12% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $16,404,000 -$2,118,000 -11% 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q3 2020 $16,957,000 -$3,237,000 -16% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $17,494,000 -$3,157,000 -15% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $18,016,000 -$3,104,000 -15% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $18,522,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $20,194,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $20,651,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $21,120,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.